Skip to main content

Table 1 Selected baseline characteristics of the study subjects

From: Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study

 

40–60 years (n = 777:777)

40–50 years (n = 333:333)

60 years (n = 444:444)

Controls

Cases

Controls

Cases

Controls

Cases

Clinical characteristicsa,b

 Age (years)c

59.8 (40.3–60.3)

59.8 (40.4–60.3)

50.0 (40.1–50.3)

50.0 (40.1–50.4)

60.0 (59.7–60.3)

60.0 (59.5–60.4)

 BMI (kg/m2)c

25.8 (21.8–31.5)

25.7 (21.7–31.4)

25.5 (22.0–31.3)

25.5 (22.0–31.3)

26.1 (21.6–31.6)

26.0 (21.4–31.5)

 Height (cm)

177 (167–187)

177 (167–186)

179 (167–189)

178 (168–187)

176 (167–186)

176 (166–186)

 Weight (kg)

81 (66–100)

81 (66–101)

81 (67–101)

81 (66–101)

82 (65–100)

81 (65–101)

 SBP (mmHg)

130 (110–165)

130 (110–165)

125 (106–155)

125 (105–153)

137 (110–170)

138 (110–170)

 DBP (mmHg)

82 (65–100)

83 (65–100)

80 (64–98)

80 (65–99)

85 (70–100)

85 (70–100)

Dietary intake (FFQ)a,b

 Energy (kcal/day)

1952 (1116–3183)

1974 (1141–3091)

1910 (1126–3032)

1985 (1155–3140)

1972 (1116–3262)

1940 (1129–3082)

 Total fat (g/day)

74.1 (39.4–133)

75.2 (40.3–129)

75.4 (42.7–133)

77.7 (37.6–129)

73.2 (36.4–135)

72.6 (40.5–131)

 FA C14:0 (g/day)

3.34 (1.34–7.28)

3.30 (1.51–7.18)

3.64 (1.59–7.30)

3.60 (1.61–7.48)

3.08 (1.25–7.22)

3.14 (1.44–6.58)

 FA C16:0 (g/day)

14.9 (7.39–27.9)

15.1 (7.89–28.1)

16.3 (8.54–28.3)

16.8 (8.11–28.5)

14.1 (7.02–27.2)

13.8 (7.73–27.4)

 FA C17:0 (g/day)

0.13 (0.03–0.33)

0.13 (0.04–0.34)

0.15 (0.04–0.33)

0.14 (0.04–0.35)

0.12 (0.03–0.34)

0.13 (0.04–0.32)

 FA C18:2 (g/day)

7.23 (3.62–15.0)

7.24 (3.64–14.8)

7.74 (4.28–17.2)

7.99 (3.82–15.7)

6.90 (3.39–13.4)

6.61 (3.51–14.1)

 FA C20:4 (g/day)

0.07 (0.03–0.17)

0.07 (0.03–0.17)

0.08 (0.03–0.18)

0.08 (0.04–0.18)

0.07 (0.03–0.15)

0.07 (0.03–0.16)

Blood parameters (OGTT; mmol/L)a,b

 Glucose (0 h)

5.5 (4.6–6.6)

5.5 (4.5–6.7)

5.4 (4.6–6.4)

5.4 (4.4–6.6)

5.5 (4.7–6.7)

5.5 (4.5–6.8)

 Glucose (2 h)

6.5 (4.0–9.5)

6.4 (4.1–9.3)

6.3 (3.9–8.6)

6.0 (3.8–8.7)

6.7 (4.1–10.3)

6.7 (4.4–9.8)

Status of glucose metabolisma,b

 NGT

541 (70)

580 (75)

255 (77)

272 (82)

286 (65)

308 (69)

 IFG

67 (9)

70 (9)

26 (8)

27 (8)

41 (9)

43 (10)

 IGT

138 (18)

93 (12)

46 (14)

23 (7)

92 (21)

70 (16)

 T2D

27 (3)

31 (4)

5 (1)

10 (3)

22 (5)

21 (5)

  1. Abbreviations: SBP systolic blood pressure, DBP diastolic blood pressure
  2. aData on each baseline characteristic were available for > 95% of the case-controls
  3. bContinuous variables are listed as median (5th–95th percentile), and categorical variables are listed as N (%)
  4. cMatching factors: age and BMI (and sample storage time)